During the past decade, WellStar Cobb Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 46 clinical trials were completed, i.e. on average, 1533.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 12 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "WellStar Cobb Hospital" #1 sponsor was "SWOG Cancer Research Network" with 30 trials, followed by "National Cancer Institute (NCI)" with 23 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "WellStar Cobb Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "WellStar Cobb Hospital" are "Breast Cancer" (12 trials), "Lung Cancer" (9 trials), "Lymphoma" (7 trials), "Colorectal Cancer" (4 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "WellStar Cobb Hospital" in a lesser frequency.

Most popular intervention types in "WellStar Cobb Hospital" are "Drug" (62 trials), "Other" (45 trials), "Biological" (33 trials), "Radiation" (10 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Paclitaxel" (11 trials), "Quality-of-Life Assessment" (11 trials), "Bevacizumab" (10 trials) and "bevacizumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "WellStar Cobb Hospital" are 57 trials for "All" genders, 20 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "WellStar Cobb Hospital". undefined are not yet recruiting, undefined are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in WellStar Cobb Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in WellStar Cobb Hospital, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".